Discover
OM
Outset Medical, Inc.
5.10
2 x 3.64
2 x 5.63
bid
ask
+
0.78
18.06%
2 @ 04:00 PM
5.03 -0.07 (1.37%)
| Ytd | 37.47% | |
| 1y | -75.40% |
4.40
day range
5.15
3.00
52 week range
21.36
| Open | 4.40 | Prev Close | 4.32 | Low | 4.40 | High | 5.15 | Mkt Cap | 94.54M |
| Vol | 318.75K | Avg Vol | 213.28K | EPS | -2.74 | P/E | N/A | Forward P/E | -0.89 |
| Beta | 1.95 | Short Ratio | 2.94 | Inst. Own | 52.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.42 | 200-d Avg | 6.24 | 1yr Est | 4.00 |
| Income Statement | |||
| Total Revenue | 27.86M | ||
| Revenues (USD) | 27.86M | ||
| Cost of Revenue | 15.77M | ||
| Gross Profit | 12.10M | ||
| Operating Expenses | 29.01M | ||
| Research and Development Expense | 5.62M | ||
| Selling, General and Administrative Expense | 23.40M | ||
| Operating Income | -16.92M | ||
| Interest Expense | 3.37M | ||
| Income Tax Expense | 217.00K | ||
| Net Income | -18.98M | ||
| Net Income Common Stock | -18.98M | ||
| Net Income Common Stock (USD) | -18.98M | ||
| Consolidated Income | -18.98M | ||
| Earnings per Basic Share | -1.03 | ||
| Earnings per Basic Share (USD) | -1.03 | ||
| Earnings per Diluted Share | -1.03 | ||
| Earning Before Interest & Taxes (EBIT) | -15.39M | ||
| Earning Before Interest & Taxes (USD) | -15.39M | ||
| Weighted Average Shares | 18.37M | ||
| Weighted Average Shares Diluted | 18.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 34.39M | ||
| Cash and Equivalents (USD) | 34.39M | ||
| Investments | 126.14M | ||
| Investments Current | 126.14M | ||
| Trade and Non-Trade Receivables | 25.32M | ||
| Current Assets | 236.71M | ||
| Property, Plant & Equipment Net | 8.56M | ||
| Total Assets | 249.45M | ||
| Debt Current | 1.82M | ||
| Total Debt | 101.61M | ||
| Current Liabilities | 37.61M | ||
| Debt Non-Current | 99.79M | ||
| Total Liabilities | 137.77M | ||
| Accumulated Retained Earnings (Deficit) | -1.19B | ||
| Accumulated Other Comprehensive Income | -73.00K | ||
| Shareholders Equity | 111.69M | ||
| Shareholders Equity (USD) | 111.69M | ||
| Assets Non-Current | 12.75M | ||
| Total Debt (USD) | 101.61M | ||
| Deferred Revenue | 13.01M | ||
| Inventory | 49.65M | ||
| Liabilities Non-Current | 100.16M | ||
| Trade and Non-Trade Payables | 1.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.18M | ||
| Net Cash Flow from Financing | 501.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.44M | ||
| Capital Expenditure | -65.00K | ||
| Issuance (Purchase) of Equity Shares | 506.00K | ||
| Issuance (Repayment) of Debt Securities | -5.00K | ||
| Net Cash Flow from Investing | 7.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.96M | ||
| Net Cash Flow from Operations | -12.84M | ||
| Share Based Compensation | 3.45M | ||